Aesthetic clinics are being cautioned against marketing their intravenous nutritional therapy (IVNT) services as a method of prevention and protection against coronavirus.
In newly release rulings by the Advertising Standards Authority (ASA) it has advised three clinics to take down their adverts.
The ASA sought the view of the Medicines and Healthcare products Regulatory Agency (MHRA) regarding the marketing language used, to which the MHRA said that any mention of coronavirus/COVID-19 in the promotion of an IVNT would bring the product under medicines regulations, as would any claim that implied treatment of, or protection from, the virus.
The complaints to the ASA highlighted that these products were not licensed as a medicine by the MHRA, therefore breaching CAP Code rules 12.1 and 12.11 (medicines, medical devices, health-related products and beauty products).
The ASA formally stated that the adverts must not appear again in their current form, and told the clinics to remove medicinal claims for unlicensed products from their advertising and not to use them in future.